Angela Hwang, Group President of the Pfizer Biopharmaceuticals Group
March 7, 2022 12:49 PM EST
Pharma
Marketing

Dig­i­tal tech boost­ed Pfiz­er com­mer­cial, R&D gains dur­ing Covid — and there’s no go­ing back, ex­ecs say

Beth Snyder Bulik

Senior Editor

Pfiz­er went dig­i­tal in a big way dur­ing the Covid pan­dem­ic — and it’s not go­ing back, ex­ec­u­tives said at Cowen’s an­nu­al health­care con­fer­ence on Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times